Childhood Cancer

2022 Ambassador – Meet Natasha, St. Baldrick’s First International Ambassador

by St. Baldrick's Foundation
February 23, 2022

Meet Natasha, a 13-year-old from Uganda, and St. Baldrick’s first International Ambassador.

Natasha in her school uniform.Natasha in her school uniform.

Read more »


Childhood Cancer

2022 Ambassador: Meet Rocco – A 5-Year-Old Full of Love, Kindness, and Faith

by St. Baldrick's Foundation
February 7, 2022

His parents told him his blood was sick when he was diagnosed with cancer. Rocco said he was sad, but he wanted to get better so he could donate his blood to help other people. This unselfish kindness and compassion are rare qualities in a five-year-old. But this is Rocco.

Rocco in hospital bed.

Read more »


Research

Using Precision Medicine to Improve Pediatric Cancer Treatment

by St. Baldrick's Foundation
January 19, 2022

What was once just a concept is now a reality: Precision pediatric cancer care to improve treatment.

Researchers can now sequence all the genes in the genome in an individual patient’s cancer to find gene changes or targets, and then in some cases, identify drugs that match those targets to improve treatment. (A genome includes all the genes in a cell, in this case, a cancer cell.)

This has absolutely transformed how doctors treat children with cancer in some cases.

Survival curve chart for ALL Schultz & Devidas, Leukemia 2014

Read more »


Real-Life Stories

The Top 2021 Messages Worth Remembering

by St. Baldrick's Foundation
December 16, 2021

As we close a difficult year, we reflect on lessons shared by childhood cancer patients and survivors who have faced adversity with grace, courage, and resilience. From their words, come some messages worth remembering now.

Sarah Swaim, age 31, two-time leukemia survivor & advocate

The St. Baldrick’s Foundation shares the top 2021 messages worth remembering. St. Baldrick’s Honored Kid, Sarah Swaim, and two-time leukemia survivor shares how having support during her cancer diagnosis helped her to keep going.

Read more »


Facts

What Is Acute Myeloid Leukemia (AML)?

by Benjamin Mizukawa, M.D.
September 3, 2021

What is acute myeloid leukemia?

Dr. Mizukawa is a past St. Baldrick’s Scholar. He explains acute myeloid leukemia symptoms, treatment, and research progress

What is acute myeloid leukemia (AML)?

Leukemia is cancer of the blood cells. Leukemia cells divide quickly and fail to mature into normal, functioning blood cells.

Acute leukemia progresses rapidly and is classified into two general subtypes:

  • When the cancer affects the lymphocytes, a type of white blood cell, it is called acute lymphoblastic leukemia, or ALL.
  • When the cancer affects other blood cell types, such as red blood cells, platelet-forming cells, and other types of white blood cells, it is called acute myeloid leukemia, or AML.

Read more »


Facts

What Is Acute Lymphoblastic Leukemia (ALL)?

by St. Baldrick's Foundation
August 12, 2021

What is acute lymphoblastic leukemia?

What is acute lymphoblastic leukemia?

Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells that normally fight infection. The cells do not grow and develop properly, filling up the bone marrow inside bones, where blood is normally made.

ALL is the most common type of childhood cancer, accounting for 35% of all cancers in children. Each year, there are about 2,900 new cases of children and adolescents diagnosed with ALL in the United States alone.

See how Phineas survived ALL because of research supported by St. Baldrick’s >

Its signs and symptoms resemble other common illnesses, which often leads to other treatments before the leukemia diagnosis is made.

Read more »


Advocacy

St. Baldrick’s 2018 Holiday Gift Guide: Gifts That Give Kids Hope!

by St. Baldrick's Foundation
November 20, 2018

The holiday season is about giving – and what better gift for your loved ones than something that helps a great cause, like taking childhood back from cancer. Not only are the items below awesome gift ideas, but a portion of each sale goes to the St. Baldrick’s Foundation.

That means every item sold helps fund lifesaving research and clinical trials that can find new and better treatments for kids with cancer.

Read more »


Childhood Cancer

When Research Offers Hope, Parents Continue to Advance the Mission

by Carlos Sandi, Dream Team Patient Advocate
October 23, 2018

I was recently invited to serve as a patient family advocate for the St. Baldrick’s / Stand Up to Cancer Pediatric Cancer Dream Team representing the National Cancer Institute. If you’re not familiar with the Dream Team and what they’re doing, it’s worth taking a few minutes to read up on the project.

In short, it’s a multi-institutional effort to accelerate cures for childhood cancer by sharing the skill, knowledge and unique resources of 8 top-notch research institutions.

Carlos Sandi with his son, Phineas

Carlos Sandi with his son, Honored Kid and Ambassador Phineas.

Read more »


Facts

What Is Juvenile Myelomonocytic Leukemia (JMML)?

by Elliot Stieglitz, M.D.
October 11, 2018

What is JMML

Dr. Elliot Stieglitz is a St. Baldrick’s Fellow at the University of California, San Francisco. He’s researching ways to help kids with JMML who don’t respond to standard treatment. He explains JMML symptoms, treatment options, and how your support is moving research forward.

What is JMML?

Juvenile myelomonocytic leukemia (JMML) is a type of blood cancer that affects young children.

Read more »


Childhood Cancer

St. Baldrick’s Top 10 Highlights of 2017

by Erinn Jessop, St. Baldrick's Foundation
January 8, 2018

2017 was a big year, full of breakthroughs, incredible stories and some pretty amazing achievements in the childhood cancer world. Join us as we reflect on St. Baldrick’s top 10 highlights of the past year — and make sure you give yourself a pat on the back, because much of this was possible because of YOU!

St. Baldrick's 2017 Highlights

Are you ready to take a trip down memory lane? Here we go …

1) Passage of the RACE Act

Read more »


 Older Posts »